Antibiotics for early-stage H. pylori-negative stomach MALT lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests antibiotics as a frontline treatment for early-stage stomach MALT lymphoma that is not caused by H. pylori. The goal is to see if antibiotics can shrink or control the lymphoma without needing chemotherapy or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of stomach lymphoma called MALT lymphoma (confirmed by biopsy).
- You have never had chemotherapy or radiation for this lymphoma.
- Your lymphoma is only in the stomach or in nearby lymph nodes (stage IE or IIE1).
- You have tested negative for H. pylori infection (using at least 5 different tests).
- You do not have other active cancers (except some skin cancers or early cervical/breast cancer).
- You are willing to give biopsy samples, blood, and stool for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a targeted drug called orelabrutinib for people with a specific type of stomach lymphoma that is linked to an active H. pylori infection. The goal is to see if the drug can help shrink or control the lymphoma.
This study is looking at people with a rare stomach lymphoma (MALT lymphoma) or people with other stomach conditions. It aims to understand more about the disease and track outcomes over time.
This trial tests whether adding H. pylori bacteria treatment to standard chemotherapy (before and after surgery) can improve outcomes for people with locally advanced stomach cancer. It combines oxaliplatin and S-1 chemo with antibiotics to clear the infection.
This study compares a treatment plan based on your genes to the standard treatment for H. pylori, a stomach infection that can cause ulcers. The goal is to see which approach works better and has fewer side effects.
This trial tests whether a new medication called anaprazole sodium, combined with other antibiotics and bismuth, can effectively cure a common stomach bacteria infection called Helicobacter pylori (H. pylori). If you have this infection and have never been treated for it before, this study might help you while contributing to medical knowledge.
This trial tests a treatment combining a probiotic (Saccharomyces boulardii) with an antibiotic (minocycline) for people who have never been treated for H. pylori infection. It aims to see if this combination works well and is safe.
Hear when a new MALT Lymphoma of Stomach trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.